Poorer Survival Outcomes for Male Breast Cancer Compared with Female Breast Cancer May Be Attributable to In-Stage Migration (original) (raw)

• Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225–49.
  Article PubMed Google Scholar
• Giordano SH, Cohen DS, Buzdar AU, Perkins G, Hortobagyi GN. Breast carcinoma in men: a population-based study. Cancer. 2004;101:51–7.
  Article PubMed Google Scholar
• Stang A, Thomssen C. Decline in breast cancer incidence in the United States: what about male breast cancer? Breast Cancer Res Treatment. 2008;112:595–6.
  Article Google Scholar
• Speirs V, Shaaban AM. The rising incidence of male breast cancer. Breast Cancer Res Treatment. 2009;115:429–30.
  Article Google Scholar
• Giordano SH. Male breast cancer: it’s time for evidence instead of extrapolation. Onkologie. 2008;31:505–6.
  Article PubMed Google Scholar
• Ciatto S, Iossa A, Bonardi R, Pacini P. Male breast carcinoma: review of amulticenter series of 150 cases. Coordinating Center and Writing Committee of FONCAM (National Task Force for Breast Cancer), Italy. Tumori. 1990;76:555–8.
  PubMed CAS Google Scholar
• Salvadori B, Saccozzi R, Manzari A, Andreola S, Conti RA, Cusumano F, et al. Prognosis of breast cancer in males: an analysis of 170 cases. Eur J Cancer. 1994;30A:930–5.
  Article PubMed CAS Google Scholar
• Donegan WL, Redlich PN, Lang PJ, Gall MT. Carcinoma of the breast in males: a multiinstitutional survey. Cancer. 1998;83:498–509.
  Article PubMed CAS Google Scholar
• Yildirim E, Berberoglu U. Male breast cancer: a 22-year experience. Eur J Surg Oncol. 1998;24:548–52.
  Article PubMed CAS Google Scholar
• Tajima N, Tsukuma H, Oshima A. Descriptive epidemiology of male breast cancer in Osaka, Japan. J Epidemiol. 2001;11:1–7.
  PubMed CAS Google Scholar
• Sandler B, Carmen C, Perry RR. Cancer of the male breast. Am Surg. 1994;60:816–20.
  PubMed CAS Google Scholar
• Thalib L, Hall P. Survival of male breast cancer patients: population-based cohort study. Cancer Sci. 2009;100:292–5.
  Article PubMed CAS Google Scholar
• Borgen PI, Senie RT, McKinnon WMP, Rosen PP. Carcinoma of the male breast: analysis of prognosis compared with matched female patients. Ann Surg Oncol. 1997:4:385–88.
  Article PubMed CAS Google Scholar
• Borgen PI, Wong GY, Vlamis V, et al. Current management of breast cancer: a review of 104 cases. Ann Surg. 1992;215:451–7.
  Article PubMed CAS Google Scholar
• Levi F, Randimbison L, La VC. Breast cancer survival in relation to sex and age. Oncology. 1992;49:413–7.
  Article PubMed CAS Google Scholar
• Cutuli B, Lacroze M, Dilhuydy JM, et al. Male breast cancer: results of the treatments and prognostic factors in 397 cases. Eur J Cancer. 1995;31A:1960–4.
  Article PubMed CAS Google Scholar
• Anan K, Mitsuyama S, Nishihara K, et al. Breast cancer in Japanese men: does sex affect prognosis? Breast Cancer. 2004;11:180–6.
  Article PubMed Google Scholar
• Hill TD, Khamis HJ, Tyczynski JE, Berkel HJ. Comparison of male and female breast cancer incidence trends, tumor characteristics, and survival. Ann Epidemiol. 2005;15:773–80.
  Article PubMed Google Scholar
• Adami, HO, Holmberg L. Malker B, Ries L. Long-term survival in 406 males with breast cancer. Br J Cancer. 1985;52:99–103.
  Article PubMed CAS Google Scholar
• Atalay C, Kanlioz M, Altinok M. Prognostic factors affecting survival in male breast cancer. J Exp Clin Cancer Res. 2003;22:29–33.
  PubMed CAS Google Scholar
• El-Tamer MB, Komenaka IK, Troxel A, et al. Men with breast cancer have better disease-specific survival than women. Arch Surg. 2004;139:1079–82.
  Article PubMed Google Scholar
• National Cancer Institute: Surveillance, Epidemiology, and End Results. Overview of the SEER Program. http://seer.cancer.gov/about/. Accessed April 21, 2009.
• Schaub NP, Maloney N, Schneider H, Feliberti E, Perry R. Changes in male breast cancer over a 30-year period. Am Surg. 2008;74:707–12.
  PubMed Google Scholar
• Nahleh ZA, Srikantiah R, Safa M, Jazieh AR, Muhleman A, Komrokji R. Male breast cancer in the Veterans Affairs population: a comparative analysis. Cancer. 2007;109:1471–7.
  Article PubMed Google Scholar
• Weiss JR, Moysich KB, Swede H. Epidemiology of male breast cancer. Cancer Epidemiol Biomarkers Prev. 2005;14:20–26.
  Article PubMed Google Scholar
• Giordano SH, Buzdar AU, Hortobagyi GN. Breast cancer in men. Ann Intern Med. 2002;137:678–687.
  PubMed Google Scholar
• Temmim L, Luqmani YA, Jarallah M, Juma I, Mathew M. Evaluation of prognostic factors in male breast cancer. Breast. 2001;10:166–75.
  Article PubMed CAS Google Scholar
• Rudlowski C, Friedrichs N, Faridi A, et al. Her-2/neu gene amplification and protein expression in primary male breast cancer. Breast Cancer Res Treat. 2004;84:215–23.
  Article PubMed CAS Google Scholar
• Avisar E, McParland E, Dicostanzo D, Axelrod D. Prognostic factors in node-negative male breast cancer. Clin Breast Cancer. 2006;7:331–5.
  Article PubMed Google Scholar
• Onami S, Ozaki M, Mortimer JE, Pal SK. Male breast cancer: an update in diagnosis, treatment, and molecular profiling. Maturitas. 2010;65(4):308–14.
  Article PubMed CAS Google Scholar
• Blin N, Kardas I, Welter C, Rys J, Niezabitowski A, Limon J, et al. Expression of the c-erbB2 proto-oncogene in male breast carcinoma: lack of prognostic significance. Oncology. 1993;50:408–11.
  Article PubMed CAS Google Scholar
• Giordano SH, Perkins GH, Broglio K, Garcia SG, Middleton LP, Buzdar AU, et al. Adjuvant systemic therapy for male breast carcinoma. Cancer. 2005;104:2359–64.
  Article PubMed Google Scholar
• Ribeiro G, Swindell R. Adjuvant tamoxifen for male breast cancer (MBC). Br J Cancer. 1992;65:252–4.
  Article PubMed CAS Google Scholar
• Goss PE, Reid C, Pintilie M, Lim R, Miller N. Male breast carcinoma: a review of 229 patients who presented to the Princess Margaret Hospital during 40 years: 1955–1996. Cancer. 1999;85:629–39.
  Article PubMed CAS Google Scholar
• Wang-Rodriguez J, Cross K, Gallagher S, Djahanban M, Armstrong JM, Wiedner N, et al. Male breast carcinoma: correlation of ER, PR, Ki-67, Her2-Neu, and p53 with treatment and survival, a study of 65 cases. Mod Pathol. 2002;15:853–61.
  Article PubMed Google Scholar
• Anderson WF, Jatoi I, Tse J, Rosenberg PS. Male breast cancer: a population-based comparison with female breast cancer. J Clin Oncol. 2010;28:232–9.
  Article PubMed Google Scholar
• Sorlie T, Perou CM, Tibshirani R, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA. 2001;98:10869–73.
  Article PubMed CAS Google Scholar
• Esteva FJ, Valero V, Pusztai L, Boehnke-Michaud L, Buzdar AU, Hortobagyi GN. Chemotherapy of metastatic breast cancer: what to expect in 2001 and beyond. Oncologist. 2001;6:133–146.
  Article PubMed CAS Google Scholar
• Wang J, Kollias J, Marsh C, Maddern G. Are males with early breast cancer treated differently from females with early breast cancer in Australia and New Zealand? Breast (Edinburgh). 2009;18:378–81.
  Google Scholar
• Gough DB, Donohue JH, Evans MM, Pernicone PJ, Wold LE, Naessens JM, et al. A 50-year experience of male breast cancer: is outcome changing? Surg Oncol. 1993;2:325–33.
  Article PubMed CAS Google Scholar
• Golshan M, Rusby J, Dominguez F, Smith BL. Breast conservation for male breast carcinoma. Breast (Edinburgh). 2007;16:653–6.
  Google Scholar
• Merrill RM, Dearden KA. How representative are the surveillance, epidemiology, and end results (SEER) program cancer data of the United States. Cancer Cause Control. 2004;15:1027–34.
  Article Google Scholar